Atara Biotherapeutics (ATRA) stock Forecast for 2022, 2023, 2024, 2025.

Atara Biotherapeutics (ATRA) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: September 19, 2021 12:38


Atara Biotherapeutics stock price online today

Analyst Target Price

33.38

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Atara Biotherapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2021, 2022, 2023?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $33.38 target price for Atara Biotherapeutics stock stock.

Today 200 Day Moving Average is the resistance level (14.35 $).

50 Day Moving Average is the resistance level (13.54 $).




Atara Biotherapeutics stock monthly Forecast

Date Rate Forecast MIN Rate MAX Rate Volati-
lity, %
21 Sep 21 16.45 16.15 16.73 3.61 %
22 Sep 21 16.59 16.21 16.82 3.78 %
23 Sep 21 16.57 16.21 16.79 3.53 %
24 Sep 21 16.65 16.33 16.91 3.55 %
25 Sep 21 17.13 16.82 17.41 3.51 %
26 Sep 21 17.39 17.19 17.67 2.82 %
27 Sep 21 17.37 17.23 17.77 3.15 %
28 Sep 21 17.30 17.15 17.52 2.15 %
29 Sep 21 17.35 17.18 17.73 3.15 %
30 Sep 21 17.47 17.17 17.65 2.78 %
01 Oct 21 17.50 17.12 17.90 4.54 %
02 Oct 21 17.56 17.23 17.87 3.67 %
03 Oct 21 18.05 17.81 18.22 2.28 %
04 Oct 21 18.05 17.62 18.38 4.30 %
05 Oct 21 17.90 17.70 18.06 2.06 %
06 Oct 21 18.10 17.95 18.30 1.97 %
07 Oct 21 17.91 17.54 18.14 3.43 %
08 Oct 21 17.78 17.61 18.06 2.54 %
09 Oct 21 17.25 17.04 17.54 2.95 %
10 Oct 21 17.49 17.25 17.65 2.31 %
11 Oct 21 17.32 17.15 17.55 2.36 %
12 Oct 21 16.93 16.79 17.08 1.72 %
13 Oct 21 16.76 16.63 17.07 2.66 %
14 Oct 21 16.89 16.65 17.23 3.47 %
15 Oct 21 17.07 16.91 17.36 2.63 %
16 Oct 21 17.48 17.30 17.82 2.97 %
17 Oct 21 17.39 16.98 17.50 3.04 %
18 Oct 21 17.48 17.29 17.60 1.79 %
19 Oct 21 17.29 17.05 17.47 2.46 %
20 Oct 21 17.43 17.25 17.77 3.00 %

ATRA daily forecast for this month


Atara Biotherapeutics stock forecast for 21.09.2021.
Estimated Average Forecasted Atara Biotherapeutics Price: 16.45 Positive intraday dynamics of the instrument is expected with 3.480% volatility is expected.

Pessimistic forecast: 16.15

Optimistic: 16.73


Atara Biotherapeutics stock forecast for 22.09.2021.
Estimated Average Forecasted Atara Biotherapeutics Price: 16.59 Positive intraday dynamics of the instrument is expected with 3.640% volatility is expected.

Pessimistic forecast: 16.21

Optimistic: 16.82


Atara Biotherapeutics stock forecast for 23.09.2021.
Estimated Average Forecasted Atara Biotherapeutics Price: 16.57 Negative intraday dynamics of the instrument is expected with 3.405% volatility is expected.

Pessimistic forecast: 16.21

Optimistic: 16.79


Atara Biotherapeutics stock forecast for 24.09.2021.
Estimated Average Forecasted Atara Biotherapeutics Price: 16.65 Positive intraday dynamics of the instrument is expected with 3.427% volatility is expected.

Pessimistic forecast: 16.33

Optimistic: 16.91


Atara Biotherapeutics stock forecast for 25.09.2021.
Estimated Average Forecasted Atara Biotherapeutics Price: 17.13 Positive intraday dynamics of the instrument is expected with 3.394% volatility is expected.

Pessimistic forecast: 16.82

Optimistic: 17.41


ATRA Forecast for 2021

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Oct 15.10 13.81 15.48 10.77 %
Nov 14.68 14.26 15.81 9.81 %
Dec 15.09 14.25 16.10 11.47 %

Atara Biotherapeutics stock forecast for this year


Atara Biotherapeutics share price average forecast for Oct 2021 is: 15.0967 The dynamics are negative.
Atara Biotherapeutics share price average forecast for Nov 2021 is: 14.68 The dynamics are negative.
Atara Biotherapeutics share price average forecast for Dec 2021 is: 15.0852 The dynamics are positive.


Atara Biotherapeutics stock Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 15.76 14.55 17.14 15.12 %
Feb 14.90 13.76 16.30 15.58 %
Mar 14.83 14.48 15.21 4.80 %
Apr 14.96 13.81 16.11 14.26 %
May 15.66 14.85 16.22 8.46 %
Jun 15.56 14.78 16.80 12.01 %
Jul 14.01 13.64 15.36 11.17 %
Aug 13.74 13.10 14.57 10.08 %
Sep 14.44 13.38 15.46 13.45 %
Oct 15.03 13.76 15.91 13.49 %
Nov 14.86 13.76 15.51 11.27 %
Dec 15.40 14.51 16.40 11.50 %

Atara Biotherapeutics stock Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 15.66 14.44 16.30 11.41 %
Feb 17.10 16.34 18.27 10.56 %
Mar 17.35 16.10 17.98 10.42 %
Apr 17.79 16.46 19.03 13.46 %
May 17.92 17.46 18.90 7.62 %
Jun 16.71 15.35 17.19 10.73 %
Jul 17.27 16.80 18.79 10.59 %
Aug 16.57 15.22 17.66 13.85 %
Sep 16.43 15.66 16.92 7.46 %
Oct 16.76 15.86 17.45 9.11 %
Nov 16.04 15.19 17.37 12.52 %
Dec 15.89 14.48 16.93 14.52 %



Atara Biotherapeutics stock Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 14.17 13.18 14.95 11.83 %
Feb 13.71 12.56 14.17 11.38 %
Mar 13.89 13.34 15.13 11.79 %
Apr 13.36 12.35 14.34 13.86 %
May 14.00 13.56 14.45 6.16 %
Jun 14.49 13.67 15.46 11.58 %
Jul 15.88 14.93 17.17 13.09 %
Aug 16.75 15.69 17.78 11.76 %
Sep 16.82 15.64 17.70 11.63 %
Oct 16.63 15.26 17.35 12.08 %
Nov 17.79 16.08 18.56 13.34 %
Dec 17.94 17.17 19.51 12.03 %

Atara Biotherapeutics stock Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 18.09 16.48 18.61 11.43 %
Feb 17.98 16.67 19.02 12.37 %
Mar 16.99 15.99 18.38 12.98 %
Apr 17.74 16.96 18.94 10.46 %
May 18.94 17.96 19.85 9.50 %
Jun 18.98 17.73 20.51 13.55 %
Jul 18.44 16.75 19.39 13.58 %
Aug 19.81 18.74 20.47 8.48 %
Sep 20.52 18.99 21.09 9.93 %
Oct 22.76 20.88 24.48 14.73 %
Nov 24.02 22.81 25.69 11.22 %
Dec 26.53 25.22 27.16 7.15 %

Atara Biotherapeutics overview

Atara Biotherapeutics Address

611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

1 328 999 000 $

EBITDA

-279 340 992

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-3.628

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

0

Forward PE

0

EV To Revenue

130.4

EV To EBITDA

0

52 Week High

26.1

52 Week Low

11.81

50 Day Moving Average

13.54

200 Day Moving Average

14.35

Shares Outstanding

84758000

Shares Float

61190000

Shares Short Prior Month

12780900

Short Ratio

22.36

Percent Insiders

0.575

Percent Institutions

103.15


Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 126.79 (17.09.2021) -0.51 %
AbbVie Inc.
ABBV 107.73 (17.09.2021) -0.32 %
Aeterna Zentaris Inc.
AEZS 0.6244 (17.09.2021) 1.64 %
Allakos Inc.
ALLK 109.18 (17.09.2021) 3.22 %
Allogene Therapeutics, Inc.
ALLO 25.38 (17.09.2021) 3.55 %
Amgen Inc.
AMGN 219.38 (17.09.2021) 0.93 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 16.08 (17.09.2021) 1.32 %
Aurora Cannabis Inc.
ACB 6.63 (17.09.2021) 0.15 %
Becton Dickinson and Company
BDX 261.95 (17.09.2021) -0.27 %
Biogen Inc.
BIIB 300.19 (17.09.2021) 0.17 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 135 (17.09.2021) -1.41 %
BioNTech SE
BNTX 359.18 (17.09.2021) -3.61 %
bluebird bio, Inc.
BLUE 18.32 (17.09.2021) 3.62 %
Boston Scientific Corp.
BSX 44.37 (17.09.2021) -1.18 %
Bristol-Myers Squibb Company
BMY 61.31 (17.09.2021) 0.13 %
Canopy Growth Corp.
CGC 14.71 (17.09.2021) -0.81 %
Castle Biosciences, Inc.
CSTL 77.32 (17.09.2021) 1.46 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 8.31 (17.09.2021) 2.09 %
Eli Lilly and Company
LLY 230.1 (17.09.2021) -0.41 %
Emergent BioSolutions Inc.
EBS 57.14 (17.09.2021) -0.57 %
Exelixis, Inc.
EXEL 20.72 (17.09.2021) 0.88 %
G1 Therapeutics, Inc.
GTHX 15.55 (17.09.2021) 8.97 %
Gilead Sciences, Inc.
GILD 71.61 (17.09.2021) 0.39 %
GlaxoSmithKline plc
GSK 38.93 (17.09.2021) -0.46 %
GoodRx Holdings, Inc.
GDRX 46.98 (17.09.2021) 2.29 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.99 (17.09.2021) 1.27 %
Inovio Pharmaceuticals, Inc.
INO 8.14 (17.09.2021) 5.03 %
Johnson & Johnson
JNJ 164.75 (17.09.2021) -0.28 %
Medtronic plc.
MDT 129.7 (17.09.2021) -0.93 %
Merck & Co., Inc.
MRK 71.68 (17.09.2021) -0.40 %
Moderna, Inc.
MRNA 430.05 (17.09.2021) -2.41 %
Novartis AG
NVS 83.48 (17.09.2021) -1.07 %
Novavax, Inc.
NVAX 237.54 (17.09.2021) 0.11 %
ObsEva SA
OBSV 3.34 (17.09.2021) 8.44 %
OrganiGram Holdings Inc.
OGI 2.4 (17.09.2021) 0.00 %
Pfizer Inc.
PFE 43.89 (17.09.2021) -1.30 %
Regeneron Pharmaceuticals, Inc.
REGN 651.88 (17.09.2021) -0.20 %
Sanofi
SNY 48.38 (17.09.2021) 0.39 %
Schrodinger, Inc.
SDGR 62.42 (17.09.2021) 2.08 %
Senseonics Holdings, Inc.
SENS 3.81 (17.09.2021) -0.26 %
Sorrento Therapeutics, Inc.
SRNE 8.25 (17.09.2021) 2.10 %
Stryker Corp.
SYK 273.03 (17.09.2021) -1.12 %
Sundial Growers Inc.
SNDL 0.7254 (17.09.2021) 0.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.99 (17.09.2021) 0.45 %
Thermo Fisher Scientific Inc.
TMO 596.8 (17.09.2021) 6.49 %
Tilray, Inc.
TLRY 12.17 (17.09.2021) 1.33 %
UnitedHealth Group, Inc.
UNH 420.16 (17.09.2021) 0.80 %
Veeva Systems Inc.
VEEV 302.14 (17.09.2021) -0.94 %
Zomedica Corp.
ZOM 0.5242 (17.09.2021) -2.80 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.23 (17.09.2021) -2.08 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.